42204- Website News Headlines (2)

Fast-Track Your mRNA-Based Vaccines & Therapeutics from Discovery to Commercialization by Ensuring Targeted Delivery, Durability & Tolerable Immunogenicity Across All Disease Indications

Welcome to the World’s Largest Industry-Dedicated Gathering for
mRNA Professionals

The world's first non-COVID mRNA approval from Moderna is spurring a new wave of candidates moving into early- to late-stage clinical development for rare, infectious and oncological indications. With tremendous strides in the industry, the 4th mRNA-Based Therapeutics Summit cements its position as the world's largest, end-to-end mRNA conference, bringing you exclusive scientific and strategic insights from the biggest players across indications and modalities.

Join 350+ mRNA experts and enthusiasts to hear previously-unseen data insights from 65+ world-class speakers from the likes of CureVac, Moderna, BioNTech and Sanofi, and gain exclusive regulatory insights from the FDA, MHRA and EMA.

Personalize your experience and select which sessions best apply to you, by navigating through 4 tracks of content catering to discovery, translation, clinical development and chemistry, manufacturing and controls. Join interactive roundtables and a CEOs’ Panel Discussion, choose from the Regulatory Affairs Strategy or Next Generation mRNA Delivery focus days, and forge meaningful connections in the dedicated networking sessions.

Access the 3-day, 4-track agenda, 65+ speaker line-up and
pre-conference focus days

A Snapshot of the 65+ Speaker Faculty

FDA - 2024 Testimonial

"This is an opportunity to better understand the industry’s needs, and explain the FDA’s expectations.”
Peter Marks, Director CBER

What to Expect:

350+

Attendees from Biopharma & Academia

65+

World-Class Speakers

24+

C-Level
Speakers

10+

Hours of In-Person Networking

4

Dedicated Tracks of Content

2

Pre-Conference Focus Days

1

CXOs' Panel Discussion

Lead Partner

Industry Partner